Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simona Zipursky

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
The Lancet. Global Health|October 20, 2023
nOPV2 development as a global effort for polio outbreak responseAnanda S Bandyopadhyay, Simona Zipursky
The Lancet. Infectious Diseases|September 26, 2022
A novel tool to eradicate an ancient scourge: the novel oral polio vaccine type 2 storyAnanda S Bandyopadhyay, Simona Zipursky
Human Vaccines|June 15, 2010
Knowledge and attitudes towards vaccines and immunization among adolescents in South AfricaSimona Zipursky, Charles Shey Wiysonge, Gregory Hussey
PLOS Global Public Health|February 9, 2024
One billion doses and WHO prequalification of nOPV2: Implications for the global polio situation and beyondAnanda S Bandyopadhyay, Laura V Cooper, Simona Zipursky
Expert Review of Vaccines|January 20, 2015
Polio endgame: the global introduction of inactivated polio vaccineManish Patel, Simona Zipursky, Walt Orenstein, et al.
The Journal of Infectious Diseases|August 26, 2017
A Supply and Demand Management Perspective on the Accelerated Global Introductions of Inactivated Poliovirus Vaccine in a Constrained Supply MarketIan Lewis, Ann Ottosen, Jennifer Rubin, et al.
Vaccine|February 25, 2014
Benefits of using vaccines out of the cold chain: delivering meningitis A vaccine in a controlled temperature chain during the mass immunization campaign in BeninSimona Zipursky, Mamoudou Harouna Djingarey, Jean-Claude Lodjo, et al.
Vaccine|March 14, 2022
Global oral poliovirus vaccine stockpile management as an essential preparedness and response mechanism for type 2 poliovirus outbreaks following global oral poliovirus vaccine type 2 withdrawalVachagan Harutyunyan, Arshad Quddus, Mark Pallansch, et al.
Vaccine|March 4, 2010
Using oral polio vaccine beyond the cold chain: a feasibility study conducted during the national immunization campaign in MaliAriane Halm, Idrissa Yalcouyé, Mady Kamissoko, et al.
Bulletin of the World Health Organization|March 14, 2014
Economic benefits of keeping vaccines at ambient temperature during mass vaccination: the case of meningitis A vaccine in ChadPatrick Lydon, Simona Zipursky, Carole Tevi-Benissan, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
The Lancet. Global Health|October 20, 2023
nOPV2 development as a global effort for polio outbreak responseAnanda S Bandyopadhyay, Simona Zipursky
The Lancet. Infectious Diseases|September 26, 2022
A novel tool to eradicate an ancient scourge: the novel oral polio vaccine type 2 storyAnanda S Bandyopadhyay, Simona Zipursky
Human Vaccines|June 15, 2010
Knowledge and attitudes towards vaccines and immunization among adolescents in South AfricaSimona Zipursky, Charles Shey Wiysonge, Gregory Hussey
PLOS Global Public Health|February 9, 2024
One billion doses and WHO prequalification of nOPV2: Implications for the global polio situation and beyondAnanda S Bandyopadhyay, Laura V Cooper, Simona Zipursky
Expert Review of Vaccines|January 20, 2015
Polio endgame: the global introduction of inactivated polio vaccineManish Patel, Simona Zipursky, Walt Orenstein, et al.
The Journal of Infectious Diseases|August 26, 2017
A Supply and Demand Management Perspective on the Accelerated Global Introductions of Inactivated Poliovirus Vaccine in a Constrained Supply MarketIan Lewis, Ann Ottosen, Jennifer Rubin, et al.
Vaccine|February 25, 2014
Benefits of using vaccines out of the cold chain: delivering meningitis A vaccine in a controlled temperature chain during the mass immunization campaign in BeninSimona Zipursky, Mamoudou Harouna Djingarey, Jean-Claude Lodjo, et al.
Vaccine|March 14, 2022
Global oral poliovirus vaccine stockpile management as an essential preparedness and response mechanism for type 2 poliovirus outbreaks following global oral poliovirus vaccine type 2 withdrawalVachagan Harutyunyan, Arshad Quddus, Mark Pallansch, et al.
Vaccine|March 4, 2010
Using oral polio vaccine beyond the cold chain: a feasibility study conducted during the national immunization campaign in MaliAriane Halm, Idrissa Yalcouyé, Mady Kamissoko, et al.
Bulletin of the World Health Organization|March 14, 2014
Economic benefits of keeping vaccines at ambient temperature during mass vaccination: the case of meningitis A vaccine in ChadPatrick Lydon, Simona Zipursky, Carole Tevi-Benissan, et al.
Pageof 3